close

Enter

Log in using OpenID

Stem Cell Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast

embed
Global Stem Cell Market is estimated to value over USD 15.5 billion by 2026 end and is expected to register a CAGR over 8.5% during the forecast period 2019 to 2026.
Stem Cell Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
Global Stem Cell Market is estimated to value over USD 15.5 billion by 2026 end and
is expected to register a CAGR over 8.5% during the forecast period 2019 to 2026.
Market Insights:
Advanced research in the development of biomaterial polymeric systems has
resulted in a significant rise in recent years. These systems are instrumental in aiding
the survival of stem cells which has boosted the market growth. Furthermore,
advancements in the treatment of damaged tissues and diseased organs coupled
with an increasing demand for regenerative medicines has propelled the market
growth significantly.
The adoption of stem cell has opened new opportunities for applications such as
wound healing therapy which has assisted in the further augmentation of the
market. The increased supply of biomaterial development used in stem cell
transplantation and induced pluripotent stem cells (iPSCs) has revolutionised the
stem cell sector. Such innovations allow researchers to create pluripotent stem cells
from adult somatic cells which aid in preserving genetic information in these cells
thus boosting the market growth.
Based on the type of product, the market is categorised as adult stem cells, human
embryonic stem cells, induced pluripotent stem cells and very small embryonic-like
stem cells. The adult stem cell segment accounts for the largest market share and is
predicted to continue this dominance during the forecast period. This is due to the
low contamination risks linked to the minimal requirement of production labour,
compatibility with the human body and sub-culturing.
Pharmaceutical companies have profitable opportunities in the stem cell sector by
initiating advancements in the identification of leading candidates thus allowing
companies to develop novel drugs. Furthermore, extensive research has advanced
the analysis of single-cell thus helping study the effects of drugs on cell
differentiation. Additionally, the growing dependence of developing entities in
cellular systems is projected to help the segment strengthen its market position in
the upcoming years.
Technology-wise, the market is bifurcated into cell acquisition, bone marrow harvest,
apheresis, umbilical blood cord, cell production, therapeutic cloning, in-vitro
fertilization, cell culture, isolation, expansion & sub-culture and cryopreservation.
The cell production technology held the largest market share due to the current
technological advancements aiming at satisfying the growing needs from different
clinical applications. A soaring number of organ replacement approaches coupled
with the rising demand for therapeutics has bolstered the market significantly. For
instance, approximately 2200 transplant surgeries that were conducted in 2016
across the world were pancreas transplants.
Depending on the type of therapy, the market is fragmented into autologous stem
cell therapy and allogeneic stem cell therapy.
Autologous stem cell therapy dominated the market concerning revenue generation
in 2018. This is mainly attributed to the consumption of autologous products on a
large scale owing to associative high compatibility. Additionally, meta-analytical
studies on the effectiveness of autologous therapy for the treatment of lower limb
disorders will propel the market further. Many companies are engaged in developing
these autologous products for patients with sport-related injuries despite it being
scrutinized by multiple government bodies.
Regional Insights:
The Asia Pacific region is projected to attain a remarkable CAGR over the forecast
period. Developed economies like Australia, Singapore and Japan are extensively
investing in the research and development projects which shall drive the market
growth. Asia Pacific countries are likely to lead the rapidly evolving stem cell
industry. Commercialization opportunities coupled with favourable regulatory
policies bolster the market expansion. Japan, in particular, has initiated regulatory
amendments related to regenerative medicine which has attracted international
manufacturers to invest massively in the Japanese market.
The key market players include STEMCELL Technologies Inc., Celegene Corp., Osiris
Therapeutics Inc., BIOTIME Inc., Advanced Cell Technology Inc. Cytori Therapeutics,
Human Longevity Inc., Cynata, Promethera Biosciences and Mesoblast.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=2344&page=requestsample
Market Segmentation:
By Product
·
Adult Stem Cells
·
Human Embryonic Stem Cells
·
Induced Pluripotent Stem Cells (iPSCs)
·
Very Small Embryonic-like Stem Cells
By Application
·
Regenerative Medicine
o Neurology
o Orthopaedics
o Oncology
o Haematology
o Cardiovascular and Myocardial Infraction
o Injuries
o Diabetes
o Liver Disorder
o Incontinence
o Others
·
Drug Discovery & Development
By Technology
·
Cell Acquisition
·
Bone Marrow Harvest
·
Umbilical Blood Cord
·
Apheresis
·
Cell Production
·
Therapeutic Cloning
·
In vitro Fertilization
·
Cell Culture
·
Isolation
·
Cryopreservation
·
Expansion and Sub-culture
By Therapy
·
Autologous
·
Allogenic
By Region
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=2344&page=askfordiscount
Competitive Landscape:
·
Tier 1 players- established companies in the market with a major market share
·
Tier 2 players
·
Emerging players which are growing rapidly
·
New Entrants
FutureWise Key Takeaways:
·
Growth prospects for stem cell market
·
SWOT analysis
·
Key trends in stem cell regeneration techniques
·
Key data-points affecting market growth
Objectives of the Study:
· To provide with an exhaustive analysis on the stem cell market by technology, by
product, by application, by therapy and by region
· To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
·
To evaluate and forecast micro-markets and the overall market
· To predict the market size, in key regions (along with countries)— North America,
Asia Pacific, Europe, Latin America and Middle East & Africa
· To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
· Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
Chapter 1 Research Methodology
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 FutureWise’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Stem cell market outlook, 2019 – 2026
Chapter 3 Stem Cell Market: Industry Outlook
3.1 Penetration & growth prospects mapping
3.2 Pipleline analysis
3.3 Trend analysis
3.3.1 Product trends
3.3.2 Application trends
3.3.3 Technology trends
3.3.4 Therapy trends
3.4 Stem Cell Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Ongoing developments in regenerative medicine
3.4.1.2 Rising funds for accelerating stem cell research
3.4.1.3 Growing demand for stem cell banking
3.4.1.4 Increasing prevalence of genetic disorders
3.4.2 Market Restraint Analysis
3.4.2.1 Ethical concern related to stem cell research
3.4.2.2 Lack of well-defined regulatory framework in certain
applications of stem cell
3.5 Opportunity analysis
3.6 Industry Analysis - Porter’s
3.6.1 Supplier power (more specifics)
3.6.2 Buyer power
3.6.3 Substitution threat
3.6.4 New entrants threat
3.7 Stem Cells - SWOT Analysis, By Factor (Political & Legal,
Economic And Technological)
3.8 Competitive landscape
3.8.1 Strategy framework
3.8.2 Company categorization
3.8.2.1 New entrants
3.8.2.2 Mature players & leaders
Chapter 4 Stem Cell Market: Product Outlook
4.1 Stem cell market share by product, 2019 to 2026
4.2 Adult stem cell market, 2019 to 2026
4.2.1 Adult stem cell market revenue (USD Million), by region
4.3 Human embryonic stem cells
4.3.1 Human embryonic stem cell market revenue (USD Million), by
region
4.4 Induced pluripotent stem cells
4.4.1 Induced pluripotent stem cell market revenue (USD Million), by
region
4.5 Very small embryonic like stem cells
4.5.1 Very small embryonic like stem cell market revenue (USD Million),
by region
Chapter 5 Stem Cell Market: Application Outlook
5.1 Stem cell market share by application, 2019 to 2026
5.2 Regenerative Medicine market, 2019 to 2026
5.2.1 Regenerative medicine market revenue (USD Million), by region
5.2.2 Neurology market, 2019 to 2026
5.2.2.1 Neurology market revenue (USD Million), by region
5.2.3 Orthopedics market, 2019 to 2026
5.2.3.1 Orthopedics market revenue (USD Million), by region
5.2.4 Oncology market, 2019 to 2026
5.2.4.1 Oncology market revenue (USD Million), by region
5.2.5 Hematology market, 2019 to 2026
5.2.5.1 Hematology market revenue (USD Million), by region
5.2.6 Cardiovascular and myocardial Infraction market, 2019 to 2026
5.2.6.1 Cardiovascular and myocardial infraction market revenue
(USD Million), by region
5.2.7 Injuries market, 2019 to 2026
5.2.7.1 Injuries market revenue (USD Million), by region
5.2.8 Diabetes market, 2019 to 2026
5.2.8.1 Diabetes market revenue (USD Million), by region
5.2.9 Liver disorder market, 2019 to 2026
5.2.9.1 Liver disorder market revenue (USD Million), by region
5.2.10 Incontinence market, 2019 to 2026
5.2.10.1 Incontinence market revenue (USD Million), by region
5.2.11 Others market, 2019 to 2026
5.2.11.1 Others market revenue (USD Million), by region
5.3 Drug discovery and development market, 2019 to 2026
5.3.1 Drug discovery and development market revenue (USD Million),
by region
Chapter 6 Stem Cell Market: Technology Outlook
6.1 Stem cell market share by technology, 2019 to 2026
6.2 Cell Acquisition market, 2019 to 2026
6.2.1 Cell acquisition market revenue (USD Million), by region
6.2.2 Bone marrow harvest market, 2019 to 2026
6.2.2.1 Bone marrow harvest market revenue (USD Million), by
region
6.2.3 Umbilical blood cord market, 2019 to 2026
6.2.3.1 Umbilical blood cord market revenue (USD Million), by region
6.2.4 Apheresis market, 2019 to 2026
6.2.4.1 Apheresis market revenue (USD Million), by region
6.3 Cell production market, 2019 to 2026
6.3.1 Cell production market revenue (USD Million), by region
6.3.2 Therapeutic cloning market, 2019 to 2026
6.3.2.1 Therapeutic cloning market revenue (USD Million), by region
6.3.3 In vitro fertilization market, 2019 to 2026
6.3.3.1 In vitro fertilization market revenue (USD Million), by region
6.3.4 Cell culture market, 2019 to 2026
6.3.4.1 Cell culture market revenue (USD Million), by region
6.3.5 Isolation market, 2019 to 2026
6.3.5.1 Isolation market revenue (USD Million), by region
6.4 Cryopreservation market, 2019 to 2026
6.4.1 Cryopreservation market revenue (USD Million), by region
6.5 Expansion and sub-culture market, 2019 to 2026
6.5.1 Expansion and sub-culture market revenue (USD Million), by
region
Chapter 7 Stem Cell Market: Therapy Outlook
7.1 Stem cell market share by therapy, 2019 to 2026
7.2 Autologous market, 2019 to 2026
7.2.1 Autologous market revenue (USD Million), by region
7.3 Allogenic
7.3.1 Allogenic market revenue (USD Million), by region
Chapter 8 Regulatory Scenario
8.1 North America
8.1.1 U.S- FDA
8.1.12 Canada
8.2 Europe
8.2 .1 Germany
8.2 .2 U.K.
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.4 Latin America
8.4.1 Brazil
8.5 Middle East & Africa (MEA)
Chapter 9.1 Stem Cell market Share by Region, 2018 & 2026
9.2 North America
9.2.1 North America stem cell market, by product 2019 - 2026 (USD
Billion)
9.2.1.1 North America adult stem cell market, by product 2019 - 2026
(USD Billion)
9.2.2 North America stem cell market, by application 2019 - 2026 (USD
Billion)
9.2.2.1 North America regenerative medicine market,
by application 2019 - 2026 (USD Billion)
9.2.3 North America stem cell market, by technology 2019 - 2026 (USD
Billion)
9.2.3.1 North America cell acquisition market, technology 2019 2026 (USD Billion)
9.2.3.2 North America cell production market, by technology 2019 2026 (USD Billion)
9.2.4 North America stem cell market, by type 2019 - 2026 (USD Billion)
9.2.5 U.S.
9.2.5.1 U.S. stem cell market, by product 2019 - 2026 (USD Billion)
9.2.5.1.1 U.S. adult stem cell market, by product 2019 - 2026 (USD
Billion)
9.2.5.2 U.S. stem cell market, by application 2019 - 2026 (USD Billion)
9.2.5.2.1 U.S. regenerative medicine market, by application 2019 2026 (USD Billion)
9.2.5.3 U.S. stem cell market, by technology 2019 - 2026 (USD Billion)
9.2.5.3.1 U.S. cell acquisition market, technology 2019 - 2026 (USD
Billion)
9.2.5.3.2 U.S. cell production market, by technology 2019 - 2026
(USD Billion)
9.2.5.4 U.S. stem cell market, by type 2019 - 2026 (USD Billion)
9.2.6 Canada
9.2.6.1 Canada stem cell market, by product 2019 - 2026 (USD
Billion)
9.2.6.1.1 Canada adult stem cell market, by product 2019 - 2026
(USD Billion)
9.2.6.2 Canada stem cell market, by application 2019 - 2026 (USD
Billion)
9.2.6.2.1 Canada regenerative medicine market,
by application 2019 - 2026 (USD Billion)
9.2.6.3 Canada stem cell market, by technology 2019 - 2026 (USD
Billion)
9.2.6.3.1 Canada cell acquisition market, technology 2019 - 2026
(USD Billion)
9.2.6.3.2 Canada cell production market, by technology 2019 2026 (USD Billion)
9.2.6.4 Canada stem cell market, by type 2019 - 2026 (USD Billion)
9.3 Europe
9.3.1 Europe stem cell market, by product 2019 - 2026 (USD Billion)
9.3.1.1 Europe adult stem cell market, by product 2019 - 2026 (USD
Billion)
9.3.2 Europe stem cell market, by application 2019 - 2026 (USD Billion)
9.3.2.1 Europe regenerative medicine market, by application 2019 2026 (USD Billion)
9.3.3 Europe stem cell market, by technology 2019 - 2026 (USD Billion)
9.3.3.1 Europe cell acquisition market, technology 2019 - 2026 (USD
Billion)
9.3.3.2 Europe cell production market, by technology 2019 - 2026
(USD Billion)
9.3.4 Europe stem cell market, by type 2019 - 2026 (USD Billion)
9.3.5 Germany
9.3.5.1 Germany stem cell market, by product 2019 - 2026 (USD
Billion)
9.3.5.1.1 Germany adult stem cell market, by product 2019 - 2026
(USD Billion)
9.3.5.1 Germany stem cell market, by application 2019 - 2026 (USD
Billion)
9.3.2.2 Germany regenerative medicine market, by application 2019 2026 (USD Billion)
9.3.5.3 Germany stem cell market, by technology 2019 - 2026 (USD
Billion)
9.3.5.3.1 Germany cell acquisition market, technology 2019 - 2026
(USD Billion)
9.3.5.3.2 Germany cell production market, by technology 2019 2026 (USD Billion)
9.3.5.4 Germany stem cell market, by type 2019 - 2026 (USD Billion)
9.3.6 U.K.
9.3.6.1 U.K. stem cell market, by product 2019 - 2026 (USD Billion)
9.3.6.1.1 U.K. adult stem cell market, by product 2019 - 2026 (USD
Billion)
9.3.6.2 U.K. stem cell market, by application 2019 - 2026 (USD
Billion)
9.3.6.2.1 U.K. regenerative medicine market, by application 2019 2026 (USD Billion)
9.3.6.3 U.K. stem cell market, by technology 2019 - 2026 (USD
Billion)
9.3.6.3.1 U.K. cell acquisition market, technology 2019 - 2026 (USD
Billion)
9.3.6.3.2 U.K. cell production market, by technology 2019 - 2026
(USD Billion)
9.3.6.4 U.K. stem cell market, by type 2019 - 2026 (USD Billion)
9.4 Asia Pacific
9.4.1 Asia Pacific stem cell market, by product 2019 - 2026 (USD Billion)
9.4.1.1 Asia Pacific adult stem cell market, by product 2019 - 2026
(USD Billion)
9.4.2 Asia Pacific stem cell market, by application 2019 - 2026 (USD
Billion)
9.4.2.1 Asia Pacific regenerative medicine market,
by application 2019 - 2026 (USD Billion)
9.4.3 Asia Pacific stem cell market, by technology 2019 - 2026 (USD
Billion)
9.4.3.1 Asia Pacific cell acquisition market, technology 2019 - 2026
(USD Billion)
9.4.3.2 Asia Pacific cell production market, by technology 2019 - 2026
(USD Billion)
9.4.4 Asia Pacific stem cell market, by type 2019 - 2026 (USD Billion)
9.4.5 Japan
9.4.5.1 Japan stem cell market, by product 2019 - 2026 (USD Billion)
9.4.5.1.1 Japan adult stem cell market, by product 2019 - 2026
(USD Billion)
9.4.5.2 Japan stem cell market, by application 2019 - 2026 (USD
Billion)
9.4.5.2.1 Japan regenerative medicine market, by application 2019
- 2026 (USD Billion)
9.4.5.3 Japan stem cell market, by technology 2019 - 2026 (USD
Billion)
9.4.5.3.1 Japan cell acquisition market, technology 2019 - 2026
(USD Billion)
9.4.5.3.2 Japan cell production market, by technology 2019 - 2026
(USD Billion)
9.4.5.4 Japan stem cell market, by type 2019 - 2026 (USD Billion)
9.4.6 China
9.4.6.1 China stem cell market, by product 2019 - 2026 (USD Billion)
9.4.6.1.1 China adult stem cell market, by product 2019 - 2026
(USD Billion)
9.4.6.2 China stem cell market, by application 2019 - 2026 (USD
Billion)
9.4.6.2.1 China regenerative medicine market, by application 2019
- 2026 (USD Billion)
9.4.6.3 China stem cell market, by technology 2019 - 2026 (USD
Billion)
9.4.6.3.1 China cell acquisition market, technology 2019 - 2026
(USD Billion)
9.4.6.3.2 China cell production market, by technology 2019 - 2026
(USD Billion)
9.4.6.4 China stem cell market, by type 2019 - 2026 (USD Billion)
9.5 Latin America
9.5.1 Latin America stem cell market, by product 2019 - 2026 (USD
Billion)
9.5.1.1 Latin America adult stem cell market, by product 2019 - 2026
(USD Billion)
9.5.2 Latin America stem cell market, by application 2019 - 2026 (USD
Billion)
9.5.2.1 Latin America regenerative medicine market,
by application 2019 - 2026 (USD Billion)
9.5.3 Latin America stem cell market, by technology 2019 - 2026 (USD
Billion)
9.5.3.1 Latin America cell acquisition market, technology 2019 - 2026
(USD Billion)
9.5.3.2 Latin America cell production market, by technology 2019 2026 (USD Billion)
9.5.4 Latin America stem cell market, by type 2019 - 2026 (USD Billion)
9.5.5 Brazil
9.5.5.1 Brazil stem cell market, by product 2019 - 2026 (USD Billion)
9.5.5.1.1 Brazil adult stem cell market, by product 2019 - 2026
(USD Billion)
9.5.5.2 Brazil stem cell market, by application 2019 - 2026 (USD
Billion)
9.5.5.2.1 Brazil regenerative medicine market, by application 2019 2026 (USD Billion)
9.5.5.3 Brazil stem cell market, by technology 2019 - 2026 (USD
Billion)
9.5.5.3.1 Brazil cell acquisition market, technology 2019 - 2026
(USD Billion)
9.5.5.3.2 Brazil cell production market, by technology 2019 - 2026
(USD Billion)
9.5.5.4 Brazil stem cell market, by type 2019 - 2026 (USD Billion)
9.6 Middle East & Africa (MEA)
9.6.1 Middle East & Africa (MEA) stem cell market, by product 2019 2026 (USD Billion)
9.6.1.1 Middle East & Africa (MEA) adult stem cell market, by product
2019 - 2026 (USD Billion)
9.6.2 Middle East & Africa (MEA) stem cell market, by application 2019 2026 (USD Billion)
9.6.2.1 Middle East & Africa (MEA) regenerative medicine market,
by application 2019 - 2026 (USD Billion)
9.6.3 Middle East & Africa (MEA) stem cell market, by technology 2019 2026 (USD Billion)
9.6.3.1 Middle East & Africa (MEA) cell acquisition market,
technology 2019 - 2026 (USD Billion)
9.6.3.2 Middle East & Africa (MEA) cell production market, by
technology 2019 - 2026 (USD Billion)
9.6.4 Middle East & Africa (MEA) stem cell market, by type 2019 - 2026
(USD Billion)
9.6.5 South Africa
9.6.5.1 South Africa stem cell market, by product 2019 - 2026 (USD
Billion)
9.6.5.1.1 South Africa adult stem cell market, by product 2019 2026 (USD Billion)
9.6.5.2 South Africa stem cell market, by application 2019 - 2026
(USD Billion)
9.6.5.2.1 South Africa regenerative medicine market,
by application 2019 - 2026 (USD Billion)
9.6.5.3 South Africa stem cell market, by technology 2019 - 2026
(USD Billion)
9.6.5.3.1 South Africa cell acquisition market, technology 2019 2026 (USD Billion)
9.6.5.3.2 South Africa cell production market, by technology 2019 2026 (USD Billion)
9.6.5.4 South Africa stem cell market, by type 2019 - 2026 (USD
Billion)
Chapter 10. Stem Cell Market: Competitive Profiles
10.1 Advanced Cell Technology Inc.
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 STEMCELL Technologies Inc.
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 BIOTIME, INC.
10.3.1 Company overview
10.3.2 Cell Cure Neurosciences LTD.
10.3.3 ESI BIO
10.3.4 Financial performance
10.3.5 Product benchmarking
10.3.6 Strategic initiatives
10.4 Cellular Engineering Technologies Inc.
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 CellGenix GmbH
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 PromoCell GmbH
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 Lonza
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Kite Pharma
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 Cellartis AB
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 Angel Biotechnology
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives
10.11 BrainStorm Cell Therapeutics
10.11.1 Company overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives
10.12 Celgene Corporation
10.12.1 Company overview
10.12.2 Financial performance
10.12.3 Product benchmarking
10.12.4 Strategic initiatives
10.13 Osiris Therapeutics
10.13.1 Company overview
10.13.2 Financial performance
10.13.3 Product benchmarking
10.13.4 Strategic initiatives
10.14 Genea BioCells
10.14.1 Company overview
10.14.2 Financial performance
10.14.3 Product benchmarking
10.14.4 Strategic initiatives
10.15 Bioheart Inc.
10.15.1 Company overview
10.15.2 Financial performance
10.15.3 Product benchmarking
10.15.4 Strategic initiatives
10.16 Waisman Biomanufacturing
10.16.1 Company overview
10.16.2 Financial performance
10.16.3 Product benchmarking
10.16.4 Strategic initiatives
10.17 TiGenix
10.17.1 Company overview
10.17.2 Financial performance
10.17.3 Product benchmarking
10.17.4 Strategic initiatives
10.18 Caladrius
10.18.1 Company overview
10.18.2 Financial performance
10.18.3 Product benchmarking
10.18.4 Strategic initiatives
10.19 Gamida Cell.
10.19.1 Company overview
10.19.2 Financial performance
10.19.3 Product benchmarking
10.19.4 Strategic initiatives
10.20 pluristem
10.20.1 Company overview
10.20.2 Financial performance
10.20.3 Product benchmarking
10.20.4 Strategic initiatives
10.21 TiGenix
10.21.1 Company overview
10.21.2 Financial performance
10.21.3 Product benchmarking
10.21.4 Strategic initiatives
11. Reccomendations and Acronyms
12. Research Methodology
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content